European Companies Search Engine
EU funding (€1,499,981): EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation Hor25 Oct 2024 EU Research and Innovation programme "Horizon"
Text
EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation
The RAFIKI consortium will support capacity building for early drug discovery in Africa with a focus on infectious diseases (e.g., malaria, tuberculosis). Sub-Saharan Africa is disproportionately burdened by such diseases yet lacks a critical mass of appropriately skilled scientists and access to general infrastructure, enabling technology platforms and expertise for drug discovery research. RAFIKI will leverage existing collaborations within the consortium to build the knowledge and technical capacities of research institutions across Africa. RAFIKI will establish regional training hubs in South, East and West Africa to support local capacity/skillset building for early-/mid-career researchers via bidirectional scientific training visits, mentorships, regional in-person workshops and online training courses. To establish the requisite infrastructure for future drug discovery R&I, knowledge and procedures will be shared for compound library curation at partner institutions (i.e., workflows, open database creation, library sharing capabilities), and data management capacities will be bolstered using the Collaborative Drug Discovery (CDD) Vault. To secure funding beyond the project lifetime, the consortium will liaise with relevant industrial actors and potential public/private funders.
Funded Companies:
| Company name | Funding amount |
| MMV MEDICINES FOR MALARIA VENTURE FONDATION | ? |
| EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (e.U.-OPENSCREEN ERIC) | €303,000 |
| H3D Foundation NPC | €276,654 |
| Kenya Medical Research Institute | €127,940 |
| Stellenbosch University | €114,104 |
| University OF Cape Town | €182,462 |
| University of Dundee | €278,079 |
| University OF Ghana | €132,148 |
| University OF Zambia | €85,595 |
Source: https://cordis.europa.eu/project/id/101188390
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: MMV MEDICINES FOR MALARIA VENTURE FONDATION, Geneva, Switzerland.
The visualizations for "MMV MEDICINES FOR MALARIA VENTURE FONDATION - EU funding (€1,499,981): EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
